Roche at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Roche takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1030. Its program centres on hormone receptor-positive, HER2-negative breast cancer in both the metastatic and early settings, including how to get the most from hormone therapy. It also covers progress in lung cancer care.

OrganizationESMO 2026 Attendance
roche.com
Large pharmaExhibitor
Swiss healthcare company with a large portfolio of cancer medicines and diagnostics, including antibodies, antibody-drug conjugates and tissue and molecular tests.
Booth
Exhibiting at Booth 1030
Satellite
Fri Oct 23
18:15–19:45
Satellite
Sun Oct 25
13:00–14:30
Satellite
Mon Oct 26
13:00–14:30
F. Hoffmann - La Roche LTD - Advancing the Frontiers of Lung Cancer Care
Sponsored session · with Georgetown Lombardi Comprehensive Cancer Center
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Roche

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction